Lung Cancer Trials Ask AI to find trials
UnknownNot applicableNCT02190864
Official study title

Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients

Study summary

Our long-term goal is to integrate non-small cell lung cancer patient treatment preferences into clinical treatment planning.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forNon-small cell lung cancer (NSCLC) · Metastatic or stage IV

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Dec 4, 2015 · Source: ClinicalTrials.gov

Is enrollment open?Unknown

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?8 U.S. locations

Locations may change over time.

Who runs it?University of Nebraska

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
University of Nebraska
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Cancer type
Non-small cell lung cancer (NSCLC)→
Disease setting
Metastatic or stage IV→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Willing and able to provide consent
  • Greater than or equal to 19 years of age
  • Diagnosed with stage IV non-small cell lung cancer (NSCLC)
  • Able to understand spoken English
  • Eligible to undergo chemotherapy for stage IV NSCLC, to include, but not limited to, those who: 1. have not yet started chemo 2. are currently undergoing chemo for stage IV NSCLC 3. have completed first line stage IV NSCLC chemo or progressed to maintenance for stage IV NSCLC within the last 30 days 4. elect to have chemo elsewhere -- not at one of the study sites 5. decline chemo
Reasons someone may not be able to joinExclusion criteria
  • Age \<19 years
  • Not willing and/or able to provide consent
  • Not able to understand spoken English
  • Not eligible to undergo chemotherapy for stage IV NSCLC

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Moffitt Cancer CenterTampa, Florida
  • Kansas City VA Medical CenterKansas City, Missouri
  • Saint Francis Cancer Treatment CenterGrand Island, Nebraska
  • Southeast Nebraska Cancer centerLincoln, Nebraska
  • Callahan Cancer Center of Great Plains Regional Medical CenterNorth Platte, Nebraska
  • Nebraska-Western Iowa (NWI) VA Health Care SystemOmaha, Nebraska
  • University of Nebraska Medical CenterOmaha, Nebraska
  • Avera Cancer InstituteSioux Falls, South Dakota

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Dec 4, 2015. Always confirm current availability with the study team.

View original record ↗